__timestamp | Jazz Pharmaceuticals plc | Teva Pharmaceutical Industries Limited |
---|---|---|
Wednesday, January 1, 2014 | 117418000 | 9216000000 |
Thursday, January 1, 2015 | 102526000 | 8296000000 |
Friday, January 1, 2016 | 105386000 | 10044000000 |
Sunday, January 1, 2017 | 110188000 | 11560000000 |
Monday, January 1, 2018 | 121544000 | 10558000000 |
Tuesday, January 1, 2019 | 127930000 | 9351000000 |
Wednesday, January 1, 2020 | 148917000 | 8933000000 |
Friday, January 1, 2021 | 440760000 | 8284000000 |
Saturday, January 1, 2022 | 540517000 | 7952000000 |
Sunday, January 1, 2023 | 435577000 | 8200000000 |
Monday, January 1, 2024 | 8480000000 |
Infusing magic into the data realm
In the ever-evolving pharmaceutical industry, understanding the cost of revenue is crucial for assessing a company's financial health. This analysis focuses on two major players: Teva Pharmaceutical Industries Limited and Jazz Pharmaceuticals plc, from 2014 to 2023.
Teva, a global leader in generic medicines, has consistently maintained a high cost of revenue, peaking in 2017 with a staggering 11.56 billion. However, a downward trend is evident, with a 31% decrease by 2022. In contrast, Jazz Pharmaceuticals, known for its innovative therapies, shows a more dynamic trajectory. Starting at 117 million in 2014, Jazz's cost of revenue surged by 360% to 540 million in 2022, reflecting its aggressive growth strategy.
This comparative analysis highlights the strategic differences between these companies, offering insights into their operational efficiencies and market positioning.
Comparing Cost of Revenue Efficiency: Johnson & Johnson vs Jazz Pharmaceuticals plc
Comparing Cost of Revenue Efficiency: Vertex Pharmaceuticals Incorporated vs Jazz Pharmaceuticals plc
Cost of Revenue Trends: Zoetis Inc. vs Teva Pharmaceutical Industries Limited
Analyzing Cost of Revenue: Teva Pharmaceutical Industries Limited and Corcept Therapeutics Incorporated
Cost of Revenue Comparison: Teva Pharmaceutical Industries Limited vs Cytokinetics, Incorporated
Cost Insights: Breaking Down Teva Pharmaceutical Industries Limited and Alkermes plc's Expenses
Cost of Revenue: Key Insights for Viatris Inc. and Jazz Pharmaceuticals plc
Comparing Cost of Revenue Efficiency: Jazz Pharmaceuticals plc vs Cytokinetics, Incorporated
Cost of Revenue Comparison: Jazz Pharmaceuticals plc vs ACADIA Pharmaceuticals Inc.
Comparing Cost of Revenue Efficiency: Jazz Pharmaceuticals plc vs Vericel Corporation
Jazz Pharmaceuticals plc vs Agios Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: Jazz Pharmaceuticals plc vs Galapagos NV